Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Chun

Showing results (131-140 of 143) with videos related to

Pageof 15
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 31, 2016
Impact of Intensity-Modulated Radiation Therapy Technique for Locally Advanced Non-Small-Cell Lung Cancer: A Secondary Analysis of the NRG Oncology RTOG 0617 Randomized Clinical TrialStephen G Chun, Chen Hu, Hak Choy, et al.
Journal for Immunotherapy of Cancer|October 27, 2020
Low-dose radiation treatment enhances systemic antitumor immune responses by overcoming the inhibitory stromaHampartsoum B Barsoumian, Rishab Ramapriyan, Ahmed I Younes, et al.
Journal for Immunotherapy of Cancer|September 6, 2019
Influence of low-dose radiation on abscopal responses in patients receiving high-dose radiation and immunotherapyHari Menon, Dawei Chen, Rishab Ramapriyan, et al.
Advances in Radiation Oncology|April 7, 2022
Adoption of Ultrahypofractionated Radiation Therapy in Patients With Breast CancerKelsey L Corrigan, Xiudong Lei, Neelofur Ahmad, et al.
International Journal of Radiation Oncology, Biology, Physics|November 1, 2024
Adding Metastasis-Directed Therapy to Standard-of-Care Systemic Therapy for Oligometastatic Breast Cancer (EXTEND): A Multicenter, Randomized Phase 2 TrialJay P Reddy, Alexander D Sherry, Bryan Fellman, et al.
JAMA Oncology|April 6, 2023
Addition of Metastasis-Directed Therapy to Intermittent Hormone Therapy for Oligometastatic Prostate Cancer: The EXTEND Phase 2 Randomized Clinical TrialChad Tang, Alexander D Sherry, Cara Haymaker, et al.
International Journal of Radiation Oncology, Biology, Physics|May 22, 2026
Long-term outcomes after proton therapy vs. intensity-modulated photon radiotherapy with concurrent chemotherapy for locally advanced non-small-cell lung cancer: post-hoc analysis of a prospective randomized trialTingshi Su, Ting Xu, Mei Chen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 12, 2020
Randomized Phase IIB Trial of Proton Beam Therapy Versus Intensity-Modulated Radiation Therapy for Locally Advanced Esophageal CancerSteven H Lin, Brian P Hobbs, Vivek Verma, et al.
Lancet (London, England)|July 21, 2023
Stereotactic ablative radiotherapy with or without immunotherapy for early-stage or isolated lung parenchymal recurrent node-negative non-small-cell lung cancer: an open-label, randomised, phase 2 trialJoe Y Chang, Steven H Lin, Wenli Dong, et al.
International Journal of Particle Therapy|July 21, 2021
Proton Therapy for Head and Neck Cancer: A 12-Year, Single-Institution ExperienceG Brandon Gunn, Adam S Garden, Rong Ye, et al.
Pageof 15

Showing results (131-140 of 143) with videos related to

Sort By:
Pageof 15
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 31, 2016
Impact of Intensity-Modulated Radiation Therapy Technique for Locally Advanced Non-Small-Cell Lung Cancer: A Secondary Analysis of the NRG Oncology RTOG 0617 Randomized Clinical TrialStephen G Chun, Chen Hu, Hak Choy, et al.
Journal for Immunotherapy of Cancer|October 27, 2020
Low-dose radiation treatment enhances systemic antitumor immune responses by overcoming the inhibitory stromaHampartsoum B Barsoumian, Rishab Ramapriyan, Ahmed I Younes, et al.
Journal for Immunotherapy of Cancer|September 6, 2019
Influence of low-dose radiation on abscopal responses in patients receiving high-dose radiation and immunotherapyHari Menon, Dawei Chen, Rishab Ramapriyan, et al.
Advances in Radiation Oncology|April 7, 2022
Adoption of Ultrahypofractionated Radiation Therapy in Patients With Breast CancerKelsey L Corrigan, Xiudong Lei, Neelofur Ahmad, et al.
International Journal of Radiation Oncology, Biology, Physics|November 1, 2024
Adding Metastasis-Directed Therapy to Standard-of-Care Systemic Therapy for Oligometastatic Breast Cancer (EXTEND): A Multicenter, Randomized Phase 2 TrialJay P Reddy, Alexander D Sherry, Bryan Fellman, et al.
JAMA Oncology|April 6, 2023
Addition of Metastasis-Directed Therapy to Intermittent Hormone Therapy for Oligometastatic Prostate Cancer: The EXTEND Phase 2 Randomized Clinical TrialChad Tang, Alexander D Sherry, Cara Haymaker, et al.
International Journal of Radiation Oncology, Biology, Physics|May 22, 2026
Long-term outcomes after proton therapy vs. intensity-modulated photon radiotherapy with concurrent chemotherapy for locally advanced non-small-cell lung cancer: post-hoc analysis of a prospective randomized trialTingshi Su, Ting Xu, Mei Chen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 12, 2020
Randomized Phase IIB Trial of Proton Beam Therapy Versus Intensity-Modulated Radiation Therapy for Locally Advanced Esophageal CancerSteven H Lin, Brian P Hobbs, Vivek Verma, et al.
Lancet (London, England)|July 21, 2023
Stereotactic ablative radiotherapy with or without immunotherapy for early-stage or isolated lung parenchymal recurrent node-negative non-small-cell lung cancer: an open-label, randomised, phase 2 trialJoe Y Chang, Steven H Lin, Wenli Dong, et al.
International Journal of Particle Therapy|July 21, 2021
Proton Therapy for Head and Neck Cancer: A 12-Year, Single-Institution ExperienceG Brandon Gunn, Adam S Garden, Rong Ye, et al.
Pageof 15